Scout, Ph.D., the head of the National LGBT Cancer Network, lays out the current state of the interplay between nicotine, cancer, HIV, and people who are LGBTQ.
Infectious-diseases researcher David Wohl, M.D., talks about a major COVID-19 treatment trial in the works—and how it relates to our efforts against HIV.
With Several Curative Therapies for Hepatitis C on the Market, the Research Pipeline for Prevention Continues
The authors of an influential annual report on hepatitis C research and development talk through what's new and evolving in clinical science.
An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.
LaRon Nelson, Ph.D., RN, talks about public health’s responsibility to meet this extraordinary moment.
Will We Ever Have a Hepatitis C Vaccine? Two Activists Weigh in on the Challenges and Opportunities Ahead
A new injection of funding from Congress could be the catalyst for a future hepatitis C (HCV) vaccine.
Natalia Linos, Sc.D., M.Sc., of Harvard University’s FXB Center for Health and Human Rights, calls for protections for low-wage essential workers and releasing people from jails, prisons, and ICE detention.
A Longtime HIV/LGBTQ Doctor Volunteered in a New York City Public Hospital Against COVID-19. Here’s What He Learned.
“It was like you were in the Lifetime movie version of a hospital,” Mayer said.
Dr. Melanie Thompson discusses what’s happening in the state around coronavirus, and what it means for people living with HIV.
Whether HIV or COVID-19, Pregnant or Lactating Cisgender Women Need to Be Included in Clinical Trials for Therapies
Dr. Shahin Lockman says to not include women in trials is unethical.